Skip to main content
. 2017 Nov 8;5(11):E1159–E1164. doi: 10.1055/s-0043-118794

Table 3. Overall rebleeding rate and rebleeding rate of the most frequent bleeding etiologies on day 3 and day 7.

Total cohort Monotherapy Salvage therapy P value
Technical success, n (%) 51/52 (98.1) 23/23 (100) 28/29 (96,6) 1
Overall rebleeding on Day 3, n (%) 22/51 (43.1)  9/23 (39.1) 13/29 (44.8) 0.78
Overall rebleeding on Day 7, n (%) 25/51 (49) 10/23 (43.5) 15/29 (51.7) 0.58
Rebleeding from peptic ulcer on Day 3, n (%)  8/18 (44.4)  3/5 (60)  5/13 (38.5) 0.61
Rebleeding from peptic ulcer on Day 7, n (%) 10/18 (55.5)  3/5 (60)  7/13 (54) 1
Rebleeding from post-interventional ulcer on Day 3, n (%)  7/14 (50)  1/4 (25)  6/10 (60) 0.56
Rebleeding from post-interventional ulcer on Day 7, n (%)  8/14 (57.1)  2/4 (50)  6/10 (60) 1
Rebleeding from tumor bleeding on Day 3, n (%)  2/10 (20)  2/7 (28.6)  0/3 1
Rebleeding from tumor bleeding on Day 7, n (%)  2/10 (20)  2/7 (28.6)  0/3 1